BioCentury | Oct 3, 2020
Emerging Company Profile
OriCiro: replacing conventional bacterial cloning
...$3.6 million in series A funding from University of Tokyo Edge Capital...
...a method of amplifying circular DNA Danielle Golovin OriCiro Genomics Inc. University of Tokyo Edge Capital University...
...a method of amplifying circular DNA Danielle Golovin OriCiro Genomics Inc. University of Tokyo Edge Capital University...